Fundraising Fox
Elutia
43 employees on LinkedIn · 1 known investors
Find your way into Elutia
Sign up to see every warm intro you have to Elutia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Elutia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction. Its allograft products serve surgeons performing reconstructive and cardiovascular repair procedures in the medical device and regenerative medicine field.
Founders & leadership
CR
C. Randal MillsFounder, President & CEODr. Randal Mills holds a doctorate in tissue sterilization and has held CEO roles at Osiris Therapeutics (where he oversaw approval of a stem cell therapeutic and commercialized cell therapy products) and Be The Match; he previously served as President of the California Institute for Regenerative Medicine and is co-founder and CEO of Elutia.
Investors · 1
In the news
Frequently asked questions
- What does Elutia do?
- Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction. Its allograft products serve surgeons performing reconstructive and cardiovascular repair procedures in the medical device and regenerative medicine field.
- Who founded Elutia?
- Elutia was founded by C. Randal Mills.
- Who are Elutia's investors?
- Elutia's investors include HighCape Capital.